ReviewOncology reviews2026

Sacituzumab tirumotecan (sac-TMT/MK-2870/SKB264): a novel antibody-drug conjugate in breast cancer.

Amalia A Sofianidi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.